Trial Profile
Study on the construction of the whole effect assessment index system over asthma with TCM and its assessment method.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Sho seiryu to
- Indications Asthma
- Focus Therapeutic Use
- 21 May 2012 Actual end date changed from 1 Oct 2010 to 31 Jan 2011 as reported by Chinese Clinical Trial Register.
- 19 Nov 2010 New trial record